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Summary
Background and objective: Several studies suggested that Chlamydia pneumoniae
(CP) infection may be a risk factor for cerebrovascular disease. Since these studies
have reported controversial results, we performed this study to identify whether Cp-
immunoglobulin was associated with atherothrombotic cerebrovascular infarction
(ACI) in Iranian patients.
Materials and methods: Forty-ﬁve patients admitted with ACI, and 45 control
without ACI were enrolled in this case—control study. Using an enzyme-linked
immunosorbed assay kit (ELISA), the presence of CP-immunoglobulin (CP-IgG) in
studied patient’s sera was determined.
Results: The seroprevalence of CP-IgG was 35(77.7%) in the ACI group (mean
age = 73.3 years) and 29(64.4%) in the control group (mean age = 70.1 years)
(P > 0.05). There was no difference in sex, age, hypertension, smoking, hyper-
lipidemia, diabetes and obesity between cases and control groups (P > 0.05). No
association was observed between CP seropositivity and ACI [OR: 1.95 (95% CI,
0.081—2.03), P = 0.16].
Conclusion:Our ﬁnding suggests that there is no association between ACI and positive
CP-IgG in Iranian patients.
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IntroductionCerebrovascular accident (CVA) is the third cause
of death worldwide. Risk factors of CVA are:
blood hypertension (BH), diabetes mellitus (DM),
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therosclerosis, hyperlipidemia, cigarette smoking,
lcohol and recent or chronic infections [1,2]. Pre-
ious studies have described acute and chronic
espiratory infection as potential risk factors for
therosclerotic vascular or cerebrovascular disease
3—5]. Several infectious agents have been found to
e involved in atherogenesis over the past decades.
hlamydia pneumoniae (CP) is an important cause
f upper respiratory tract infection and pneumo-
ia in children and young adults and is a cause
Sciences. Published by Elsevier Ltd. All rights reserved.
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Table 1 Demographic characteristics and risk factors of cerebrovascular disease in studied subjects.
Risk factors ACI group (n = 45) N (%) Control group (n = 45) N (%) P value
Sex, female 30(66.6) 30(66.6) 0.58
Age (years) 73.3± 15 70.1± 13.5 0.289
Hypertension 23(51.1) 19(42.2) 0.26
Hyperlipidemia 27(60) 30(66.6) 0.33
Cigarette smoker 18(40) 20(44.4) 0.41
Diabetes mellitus 20(44.4) 19(42.2) 0.50
Over weight 16(35.5) 18(40) 0.41
ACI; atherothrombotic cerebrovascular infarction, hypertension; systolic above 140mmhg and diastolic above 90mmhg, hyper-
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ilipidemia; serum triglyceride above 180mg/dl and or cholest
per day for more than 5 years, diabetes mellitus; fasting blood
by the square of the height (m2) more than 27, P value lower
f recurrent respiratory infection in older adults
4]. Diagnosis of CP infection is currently difﬁcult
ecause cell culture techniques are not available
or clinical use [4] and nonculture tests using anti-
en detection methods or DNA polymerase chain
eaction (PCR) are expensive and are not avail-
ble every where. Varying level of anti CP-IgG
ntibody titer have frequently been used as pre-
umptive markers of persistent, or chronic infection
tatus [5]. Recently introduced enzyme-linked
mmunosorbent assay (ELISA) kits are available and
re more objective [3,6]. Numerous studies have
inked CP infection to atherosclerosis [6]. Infection
f the vascular wall with CP has been liked to stroke
n epidemiological studies [7—11]. Kawashima and
awada demonstrated a signiﬁcant elevation of
P-immunoglobulin (CP-IgG) in an ischemic stroke
atient [12]. Since the association between anti-
odies against CP and CVA is yet controversial
13—16] and because, there are no studies exam-
ning the relation ship between the presence of CP
ntibodies level and CVA in Iran, we conducted this
ase—control study. The aim of the present study
as to ascertain whether CP-IgG positivity was asso-
iated with ACI in hospitalized subjects.
aterials and methods
inety hospitalized patients participated in this
ase—control study. The study population was
ecruited from the internal medicine department
n Naft Great Hospital in Ahvaz a city southern
ran. From December 2004 to May 2005, forty-ﬁve
atients with CVA and 45 control subjects with-
ut a history of CVA were investigated. Whereas
ases were admitted patients with CVA, control
ubjects were selected from consecutive admit-
ed patients without CVA. CVA was diagnosed by
n expert neurologist clinically with or without
s
c
b
cbove 200mg/dl, cigarette smoker; more than 10 cigarrettes
r above 140mg/dl, Over weight; body mass index (kg) divided
0.05 is signiﬁcant.
rain CT scan. Including criteria were: age of
0 years or more and admission to the hospital
nder care of specialist physician. Exclusion criteria
ere: non-thrombotic brain infarction (e.g. septic
r fat emboli) and cardiac disorders with embolism.
ndividuals with immunodeﬁciency, collagen vas-
ular disease and other autoimmune disorders,
ecause of the interference with IgG production
ere excluded. Controls who had a history of
troke or infectious disease on admission were
lso excluded. CVA was deﬁned according to the
merican Neurology Association (ANA) as a clini-
al syndrome characterized by clinical signs and
ymptoms of focal or global loss of brain func-
ion with no apparent cause other than of vascular
rigin. This deﬁnition was made with either a
ormal brain CT scan, or evidence of an infarct
n the clinically relevant area of the brain on a
T Scan. Five milliliter of clotted blood samples
btained from each case and control subjects and
ere preserved at −20◦C until the time of sero-
ogical assays. Immunoglobulin G (IgG) antibodies
gainst CP were tested by using the DIA Pro CP
nzyme-linked immunosorbent assay (Milan, Italy)
ccording to manufacturer’s instructions. Out of
otal samples, 10 samples were randomly selected
nd retested to detect CP-IgG. No difference was
bserved between results of duplicate tests. Sen-
itivity and speciﬁcity of the test was more than
8%. According to manufacturer’s instructions, cut
ff for the CP-IgG was 10 IU. Those with titers
f 10 IU or above were determined as seroposi-
ive and those with titers below the 10 IU were
onsidered seronegative. Data about other risk fac-
ors was collected by a questionnaires including
ender, age, blood pressure, body weight, smok-
ng, triglyceride/cholesterol serum levels and blood
ugar (DM=diabetes mellitus). Data was statisti-
ally analyzed by using SPSS 11.5, and compared
y chi square test. A value of P below 0.05 was
onsidered signiﬁcant.
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Table 2 Distribution of chlamydia pneumoniae seropositivity in cases and controls.
Serological status Case (n = 45) N (%) Control (n = 45) N = (%) OR (95%CI) P value
CP-seropositive 35(77.7) 29(64.4) 1.95(0.81—2.03) 0.16
5.5)
rone
i
a
t
C
W
m
s
w
b
a
a
i
d
I
o
6
s
v
s
c
c
C
T
b
a
n
f
C
F
C
E
ACP-seronegative 10(22.3) 16(3
Chlamydia pneumoniae (CP) seropositive; CP-IgG≥ 10, CP se
interval, P value lower than 0.05 is signiﬁcant.
Results
In this study, mean age of the participants was
71.5± 14.2 years. Mean age of the cases and con-
trols was 73.3± 15 and 70.1± 13.5, respectively.
Female to male ratio in cases and controls was
2:1. Demographic characteristics and risk factors
of ACI in patients with CVA and controls are shown
in Table 1. There were no signiﬁcant differences in
gender, age, DM, Hypertension, cigarette smoking,
cardiovascular disease and over weight between
cases and controls (P > 0.05). Prevalence of CP-IgG
in cases and controls are shown in Table 2. As shown
in Table 2, we found that 35(77.7%) of cases and
29(64.4%) of controls were CP seropositive. There
was no signiﬁcant difference between patients with
ACI and controls in the distribution of CP seroposi-
tivity (P > 0.05). As shown in Table 2, OR (odds ratio)
indicating no association between the risk of ACI
and CP-IgG was 1.95 [95% conﬁdence interval (CI),
0.81—2.03].
Discussion
The present study revealed no difference in CP
seropositivity between CVA patients with ACI and
control subjects in the small Iranian sample stud-
ied. The results of this study also suggested that
CP seropositivity is not associated with ACI. Previ-
ous studies have suggested that infection with CP is
associated with an increased risk of cerebrovascu-
lar disease [7—11]. Cook et al. in their study showed
that CP antibody titers are signiﬁcantly associated
with acute stroke [7]. Wimmer et al. described
an association between CVA and Chlamydia infec-
tion [8]. Elkind et al. stated that CP infection
is a risk factor for stroke [9]. Kawamoto et al.,
Virok et al., Madre et al. also described association
between CP and stroke [6,10,11]. In other studies
CP infection was not associated with cerebrovas-
cular disease [12,14—16]. Kawashima and Kawada,
Jahromni et al., Sirmatel et al. and Heuschmann
et al. reported that they observed no associa-
tion between CP infection and stroke. We believe
that differences of these results may be due to
the fact that sample size in our study (and sim-
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gative; CP-IgG < 10, Or (95%CI); Odds Ratio 95% conﬁdence
lar studies) was too small for detection of an
ssociation between CP infection and ACI, or that
he method which was employed for detection of
P infection was different between the studies.
e measured only IgG anti CP antibody titer by
eans of an ELISA method, whereas others mea-
ured IgG, IgM and IgA. In some studies CP infection
as determined by CP-DNA-PCR. Differentiation
etween recent infection and past infection is not
chieved by CP-IgG measurement, whereas PCR
nd IgM is more reliable test with higher sensitiv-
ty and speciﬁcity [4,5]. Another reason for these
ifferences may be due to age of the patients.
n our study patients were 40 years of age or
lder, whereas in other studies the age was above
5 years.
Limitations of the present study include: (1)
tudied subjects were hospitalized patients with
arious diseases, (2) our study was based on a small
ample size (3) diagnosis of stroke was based on
linical ﬁnding, and controls could have had sub
linical stroke.
onclusion
he present study does not support an association
etween previous CP infection and ACI in Iranian
dmitted patients living in Ahvaz. Larger studies are
eeded to clarify whether infection with CP is a risk
actor for cerebrovascular accident.
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